Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

TDOC US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Teladoc Health, Inc.(TDOC US)

$8.88+0.182.13%(Market Open · 16:38:31 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

TDOC US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Teladoc Health, Inc.(TDOC US)

$8.88+0.182.13%(Market Open · 16:38:31 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Teladoc Health, Inc. — Company Profile

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Sector
Consumer Staples
Industry
Personal Care Products
Exchange
UN
CEO
Charles Divita
Headquarters
New York, NY, US
IPO Date
Jun 30, 2015
Employees
5,124
Website
www.teladochealth.com

Key Metrics

Price
$5.52
Market Cap
$1.00B
Revenue (TTM)
$613.85M
Net Income (TTM)
$-63837000.00
EPS (TTM)
-0.36
P/E (TTM)
-5.86
P/B (TTM)
0.75
Dividend Yield
0.00%
ROE (TTM)
-4.78%
ROA (TTM)
-2.27%
Operating Margin
-7.94%
Beta
0.89

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Website
www.teladochealth.com
Location
New York, NY, US
Phone203 635 2002
Employees5,124
CEOCharles Divita
Sector
Consumer Staples
Industry
Personal Care Products
IPO DateJun 30, 2015

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.6K)

Expand
  • Form 4Nueno Carlos9 Nov
  • Form 144Nueno Carlos6 Nov
  • Form 3Dorfman Jonathan3 Nov
  • 10-QQ3ended 30 Sept 202629 Oct
  • 8-KResults of Operations and Financial Condition28 Oct
  • SC 13GTeladoc Health, Inc.8 Oct
  • Form 4Catapano Joseph Ronald5 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers25 Sep
  • Form 4DIVITA CHARLES III14 Sep
  • Form 144DIVITA CHARLES III11 Sep
  • Form 4Nueno Carlos3 Sep
  • Form 4Vandervoort Adam C3 Sep
  • Form 4Bliss Kelly3 Sep
  • Form 4Catapano Joseph Ronald3 Sep
  • Form 4DIVITA CHARLES III3 Sep
  • Form 4Rodrigues Fernando M.3 Sep
  • Form 144Rodrigues Fernando M.3 Sep
  • Form 144Bliss Kelly2 Sep
  • Form 144Rodrigues Fernando M.2 Sep
  • Form 144Vandervoort Adam C2 Sep

News

  • Teladoc Health Canada Named Strategic Innovation Partner by NL Health Services to Advance Virtual Care Across the Province12 Nov
  • A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift11 Nov
  • Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.083 Nov
  • Teladoc Soars 26% as Revenue and Profit Beat Estimates; Hims & Hers Health and American Well Tick Up29 Oct
  • Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook29 Oct
  • Teladoc Health, Inc. (TDOC) Q3 2026 Earnings Call Transcript29 Oct
  • Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.29 Oct
  • Teladoc Health Q3 Earnings Call Highlights29 Oct
  • Teladoc: 3 Key Takeaways for Long-Term Investors29 Oct
  • Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates28 Oct
  • Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates28 Oct
  • Teladoc Health Reports Third Quarter 2026 Results28 Oct
  • Unveiling Teladoc (TDOC) Q3 Outlook: Wall Street Estimates for Key Metrics27 Oct
  • Teladoc (TDOC) Outperforms Broader Market: What You Need to Know19 Oct
  • Teladoc Health, Inc. $TDOC Shares Acquired by Counterpoint Mutual Funds LLC18 Oct
  • Teladoc Health to Announce Third Quarter 2026 Financial Results14 Oct
  • Teladoc (TDOC) Rises As Market Takes a Dip: Key Facts13 Oct
  • Analyzing Teladoc Health (NYSE:TDOC) & Schrodinger (NASDAQ:SDGR)12 Oct
  • Teladoc Strengthens Solo Platform With New AI-Powered Care Tools8 Oct
  • Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know7 Oct

Mentions in Filings

  • … of digital health companies, including direct competition from competitors offering cardiometabolic programs, such as 9amHealth Inc., Calibrate Health, Inc., Hello Heart Inc., Lark Technologies, Inc., Livongo (via <strong>Teladoc Health, Inc.</strong>), Twin Health, Inc., Vida Health, Inc., and Virta Health Corp.; competitors offering only MSK programs, such as Hinge Health, Inc.; and those that offer both cardiometabolic and MSK programs, such as SWORD Health, …
    Omada Health, Inc.Teladoc Health, Inc.·10-Q - Quarterly report Q3·Q3 26·6 Nov
  • … to that, Mr. Anquillare served as Verisk’s Chief Financial Officer from 2007 to 2016, leading the company through its 2009 initial public offering. Since August 2026, he has also served on the board of directors of <strong>Teladoc Health, Inc.</strong>, a global leader in virtual care, where he serves on its audit and compensation committees. From 2023 through its acquisition by IKS Health in July 2026, he served on the board of directors of TruBridge, Inc., a he …
    Guidewire Software, Inc.Teladoc Health, Inc.·DEF 14A - Definitive proxy statement·Q4 26·29 Oct
  • … nd execution of definitive agreements; the satisfaction or waiver of closing conditions; the receipt of stockholder and other required approvals; the outcome of the litigation between Data Health Partners, Inc. and <strong>Teladoc Health, Inc.</strong>; the value, validity and enforceability of the intellectual property described; demand for Tollo Health and GLP-1 adjunct products; fulfillment of Health Lives Here prescriptions; the development of a proprietary b …
    DataMeds AI, Inc.Teladoc Health, Inc.·EX-99.1 - 8-K - Entry into a Material Definitive Agreement·Q4 26·26 Oct
  • **Exhibit 99.1** **POMDOCTOR LIMITED Highlights Differentiated “Hardware + AI + Payment” Healthcare Infrastructure Model** GUANGZHOU, China, September 24, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today highlighted its differentiated “hardware + AI + payment” infrastructure model. The Company believes this integrated app …
    POMDOCTOR LtdTeladoc Health, Inc.·EX-99.1 - 6-K - PRESS RELEASE - POMDOCTOR LIMITED HIGHLIGHTS DIFFERENTIATED "HARDWARE + AI + PAYMENT" HEALTHCARE INFRASTRUCTURE MODEL·Q3 26·24 Sep
  • … lytics from 2007 to 2016. Before joining Verisk, Mr. Anquillare worked at Prudential Financial, focusing on life insurance and property and casualty operations. Since 2026, Mr. Anquillare has served on the board of <strong>Teladoc Health, Inc.</strong> (NYSE: TDOC), a leading virtual care provider, where he also serves on the audit and compensation committees. Since 2024, Mr. Anquillare has served on the board of directors of Guidewire Software, Inc. (NYSE: GWRE) …
    Bamboo Insurance Services, Inc.Teladoc Health, Inc.·S-1/A - Registration statement (general form, amendment)·Q3 26·14 Sep
  • … Analytics from 2007 to 2016. Before joining Verisk, Mr. Anquillare worked at Prudential Financial, focusing on life insurance and property and casualty operations. Since 2026, Mr. Anquillare has served on the board of <strong>Teladoc Health</strong> (NYSE: TDOC), a leading virtual care provider, where he also serves on the audit and compensation committees. Since 2024, Mr. Anquillare has served on the board of directors of Guidewire (NYSE: GWRE), a leading platfo …
    Bamboo Insurance Services, Inc.Teladoc Health, Inc.·S-1 - Registration statement (general form)·Q3 26·28 Aug

Key Stats

Trading

Px/Chg 1D$5.52 / -2.65%
Avg Volume5.10M
Beta0.89
Mkt Cap1.00B
FD Mkt Cap1.16B

Float

Shrs Out/Float181.68M / 180.51M
Short Float0.16%
Days to Cover5.72
Stock Repurchased$0.00

Current Valuation

EV1.29B
EV/EBITDA22.51
EV/Sales0.51
P/B0.75
P/S0.40
FCF Yield0.78%
ROE-4.78%
ROA-2.27%
Current Ratio2.80

Estimates

P/E-5.86
Est P/E0.00
Est EPS-0.34
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Apr '24Apr '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-13.75-0.32-9.81-1.22-41.70-15.71
Price / Sales1.281.820.830.481.631.63
Price / Book Value1.031.890.930.820.760.75
Price / Free Cash Flow36.1525.2911.164.3412.32127.66
ENTERPRISE VALUE METRICS
Enterprise Value2,356.05,039.42,630.31,512.61,307.61,290.2
Enterprise Value / Sales1.572.091.010.592.042.10
Enterprise Value / EBITDA-100.34-668.6260.3147.6825.5833.33
Enterprise Value / EBIT-22.36-23.17-12.50-7.24-45.61-23.26

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue5.6%2,032.72,406.82,602.42,569.62,530.0
Gross Income6.2%1,382.41,662.91,842.41,818.31,758.4
EBITDA—-31.4-7.543.631.7147.3
EBIT-2.5%-239.0-217.5-210.5-208.8-215.8
Net Income-17.3%-428.8-13,659.5-220.4-1,001.2-200.3
EPS (Diluted)-19.6%-2.73-84.60-1.34-5.87-1.14
BALANCE SHEET
Cash & ST Inv-3.4%896.0918.21,123.71,298.3781.1
Total Assets-35.3%17,734.64,701.04,392.43,516.53,100.8
Total Liabilities38.6%1,688.92,393.22,066.32,025.41,715.1
Total Shareholder Equity-45.8%16,045.82,307.72,326.11,491.11,385.7
CASH FLOW
Net Operating Cash Flow11%194.0189.3350.0293.7294.4
Cap Ex1%-8.5-16.5-156.3-10.8-8.9
Free Cash Flow11.4%185.5172.8193.7282.9285.5

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)8.73
Basic Shares181.68
Market Cap1,586.1
Diluted Shares181.88
Fully Diluted Shares Outstanding181.88
Fully Diluted Market Cap1,587.8
+Consolidated Debt1,025.7
−In-the-Money Convertible Debt—
+Capital Leases28.1
+Operating Leases—
−Cash & Equivalents-849.9
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value1,761.9

Segment data

Revenue

by Products and services

  • Other100%

Revenue

by Geography

  • United States82%
  • Non-us18%

Related companies

HCA Healthcare, Inc.

HCA US

Tenet Healthcare Corp

THC US

Universal Health Services Inc

UHS US

Hims & Hers Health, Inc.

HIMS US

Surgery Partners, Inc.

SGRY US

Community Health Systems Inc

CYH US

Auna S.a.

AUNA US

PHYHEALTH Corp

OSCI US

Basel Medical Group Ltd

BMGL US

Rennova Health, Inc.

RNVA US

Cardiff Lexington Corp

CDIX US

Teladoc Health, Inc. — Company Profile

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Sector
Consumer Staples
Industry
Personal Care Products
Exchange
UN
CEO
Charles Divita
Headquarters
New York, NY, US
IPO Date
Jun 30, 2015
Employees
5,124
Website
www.teladochealth.com

Key Metrics

Price
$5.52
Market Cap
$1.00B
Revenue (TTM)
$613.85M
Net Income (TTM)
$-63837000.00
EPS (TTM)
-0.36
P/E (TTM)
-5.86
P/B (TTM)
0.75
Dividend Yield
0.00%
ROE (TTM)
-4.78%
ROA (TTM)
-2.27%
Operating Margin
-7.94%
Beta
0.89

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Website
www.teladochealth.com
Location
New York, NY, US
Phone203 635 2002
Employees5,124
CEOCharles Divita
Sector
Consumer Staples
Industry
Personal Care Products
IPO DateJun 30, 2015

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.6K)

Expand
  • Form 4Nueno Carlos9 Nov
  • Form 144Nueno Carlos6 Nov
  • Form 3Dorfman Jonathan3 Nov
  • 10-QQ3ended 30 Sept 202629 Oct
  • 8-KResults of Operations and Financial Condition28 Oct
  • SC 13GTeladoc Health, Inc.8 Oct
  • Form 4Catapano Joseph Ronald5 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers25 Sep
  • Form 4DIVITA CHARLES III14 Sep
  • Form 144DIVITA CHARLES III11 Sep
  • Form 4Nueno Carlos3 Sep
  • Form 4Vandervoort Adam C3 Sep
  • Form 4Bliss Kelly3 Sep
  • Form 4Catapano Joseph Ronald3 Sep
  • Form 4DIVITA CHARLES III3 Sep
  • Form 4Rodrigues Fernando M.3 Sep
  • Form 144Rodrigues Fernando M.3 Sep
  • Form 144Bliss Kelly2 Sep
  • Form 144Rodrigues Fernando M.2 Sep
  • Form 144Vandervoort Adam C2 Sep

News

  • Teladoc Health Canada Named Strategic Innovation Partner by NL Health Services to Advance Virtual Care Across the Province12 Nov
  • A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift11 Nov
  • Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.083 Nov
  • Teladoc Soars 26% as Revenue and Profit Beat Estimates; Hims & Hers Health and American Well Tick Up29 Oct
  • Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook29 Oct
  • Teladoc Health, Inc. (TDOC) Q3 2026 Earnings Call Transcript29 Oct
  • Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.29 Oct
  • Teladoc Health Q3 Earnings Call Highlights29 Oct
  • Teladoc: 3 Key Takeaways for Long-Term Investors29 Oct
  • Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates28 Oct
  • Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates28 Oct
  • Teladoc Health Reports Third Quarter 2026 Results28 Oct
  • Unveiling Teladoc (TDOC) Q3 Outlook: Wall Street Estimates for Key Metrics27 Oct
  • Teladoc (TDOC) Outperforms Broader Market: What You Need to Know19 Oct
  • Teladoc Health, Inc. $TDOC Shares Acquired by Counterpoint Mutual Funds LLC18 Oct
  • Teladoc Health to Announce Third Quarter 2026 Financial Results14 Oct
  • Teladoc (TDOC) Rises As Market Takes a Dip: Key Facts13 Oct
  • Analyzing Teladoc Health (NYSE:TDOC) & Schrodinger (NASDAQ:SDGR)12 Oct
  • Teladoc Strengthens Solo Platform With New AI-Powered Care Tools8 Oct
  • Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know7 Oct

Mentions in Filings

  • … of digital health companies, including direct competition from competitors offering cardiometabolic programs, such as 9amHealth Inc., Calibrate Health, Inc., Hello Heart Inc., Lark Technologies, Inc., Livongo (via <strong>Teladoc Health, Inc.</strong>), Twin Health, Inc., Vida Health, Inc., and Virta Health Corp.; competitors offering only MSK programs, such as Hinge Health, Inc.; and those that offer both cardiometabolic and MSK programs, such as SWORD Health, …
    Omada Health, Inc.Teladoc Health, Inc.·10-Q - Quarterly report Q3·Q3 26·6 Nov
  • … to that, Mr. Anquillare served as Verisk’s Chief Financial Officer from 2007 to 2016, leading the company through its 2009 initial public offering. Since August 2026, he has also served on the board of directors of <strong>Teladoc Health, Inc.</strong>, a global leader in virtual care, where he serves on its audit and compensation committees. From 2023 through its acquisition by IKS Health in July 2026, he served on the board of directors of TruBridge, Inc., a he …
    Guidewire Software, Inc.Teladoc Health, Inc.·DEF 14A - Definitive proxy statement·Q4 26·29 Oct
  • … nd execution of definitive agreements; the satisfaction or waiver of closing conditions; the receipt of stockholder and other required approvals; the outcome of the litigation between Data Health Partners, Inc. and <strong>Teladoc Health, Inc.</strong>; the value, validity and enforceability of the intellectual property described; demand for Tollo Health and GLP-1 adjunct products; fulfillment of Health Lives Here prescriptions; the development of a proprietary b …
    DataMeds AI, Inc.Teladoc Health, Inc.·EX-99.1 - 8-K - Entry into a Material Definitive Agreement·Q4 26·26 Oct
  • **Exhibit 99.1** **POMDOCTOR LIMITED Highlights Differentiated “Hardware + AI + Payment” Healthcare Infrastructure Model** GUANGZHOU, China, September 24, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today highlighted its differentiated “hardware + AI + payment” infrastructure model. The Company believes this integrated app …
    POMDOCTOR LtdTeladoc Health, Inc.·EX-99.1 - 6-K - PRESS RELEASE - POMDOCTOR LIMITED HIGHLIGHTS DIFFERENTIATED "HARDWARE + AI + PAYMENT" HEALTHCARE INFRASTRUCTURE MODEL·Q3 26·24 Sep
  • … lytics from 2007 to 2016. Before joining Verisk, Mr. Anquillare worked at Prudential Financial, focusing on life insurance and property and casualty operations. Since 2026, Mr. Anquillare has served on the board of <strong>Teladoc Health, Inc.</strong> (NYSE: TDOC), a leading virtual care provider, where he also serves on the audit and compensation committees. Since 2024, Mr. Anquillare has served on the board of directors of Guidewire Software, Inc. (NYSE: GWRE) …
    Bamboo Insurance Services, Inc.Teladoc Health, Inc.·S-1/A - Registration statement (general form, amendment)·Q3 26·14 Sep
  • … Analytics from 2007 to 2016. Before joining Verisk, Mr. Anquillare worked at Prudential Financial, focusing on life insurance and property and casualty operations. Since 2026, Mr. Anquillare has served on the board of <strong>Teladoc Health</strong> (NYSE: TDOC), a leading virtual care provider, where he also serves on the audit and compensation committees. Since 2024, Mr. Anquillare has served on the board of directors of Guidewire (NYSE: GWRE), a leading platfo …
    Bamboo Insurance Services, Inc.Teladoc Health, Inc.·S-1 - Registration statement (general form)·Q3 26·28 Aug

Key Stats

Trading

Px/Chg 1D$5.52 / -2.65%
Avg Volume5.10M
Beta0.89
Mkt Cap1.00B
FD Mkt Cap1.16B

Float

Shrs Out/Float181.68M / 180.51M
Short Float0.16%
Days to Cover5.72
Stock Repurchased$0.00

Current Valuation

EV1.29B
EV/EBITDA22.51
EV/Sales0.51
P/B0.75
P/S0.40
FCF Yield0.78%
ROE-4.78%
ROA-2.27%
Current Ratio2.80

Estimates

P/E-5.86
Est P/E0.00
Est EPS-0.34
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Apr '24Apr '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-13.75-0.32-9.81-1.22-41.70-15.71
Price / Sales1.281.820.830.481.631.63
Price / Book Value1.031.890.930.820.760.75
Price / Free Cash Flow36.1525.2911.164.3412.32127.66
ENTERPRISE VALUE METRICS
Enterprise Value2,356.05,039.42,630.31,512.61,307.61,290.2
Enterprise Value / Sales1.572.091.010.592.042.10
Enterprise Value / EBITDA-100.34-668.6260.3147.6825.5833.33
Enterprise Value / EBIT-22.36-23.17-12.50-7.24-45.61-23.26

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue5.6%2,032.72,406.82,602.42,569.62,530.0
Gross Income6.2%1,382.41,662.91,842.41,818.31,758.4
EBITDA—-31.4-7.543.631.7147.3
EBIT-2.5%-239.0-217.5-210.5-208.8-215.8
Net Income-17.3%-428.8-13,659.5-220.4-1,001.2-200.3
EPS (Diluted)-19.6%-2.73-84.60-1.34-5.87-1.14
BALANCE SHEET
Cash & ST Inv-3.4%896.0918.21,123.71,298.3781.1
Total Assets-35.3%17,734.64,701.04,392.43,516.53,100.8
Total Liabilities38.6%1,688.92,393.22,066.32,025.41,715.1
Total Shareholder Equity-45.8%16,045.82,307.72,326.11,491.11,385.7
CASH FLOW
Net Operating Cash Flow11%194.0189.3350.0293.7294.4
Cap Ex1%-8.5-16.5-156.3-10.8-8.9
Free Cash Flow11.4%185.5172.8193.7282.9285.5

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)8.73
Basic Shares181.68
Market Cap1,586.1
Diluted Shares181.88
Fully Diluted Shares Outstanding181.88
Fully Diluted Market Cap1,587.8
+Consolidated Debt1,025.7
−In-the-Money Convertible Debt—
+Capital Leases28.1
+Operating Leases—
−Cash & Equivalents-849.9
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value1,761.9

Segment data

Revenue

by Products and services

  • Other100%

Revenue

by Geography

  • United States82%
  • Non-us18%

Related companies

HCA Healthcare, Inc.

HCA US

Tenet Healthcare Corp

THC US

Universal Health Services Inc

UHS US

Hims & Hers Health, Inc.

HIMS US

Surgery Partners, Inc.

SGRY US

Community Health Systems Inc

CYH US

Auna S.a.

AUNA US

PHYHEALTH Corp

OSCI US

Basel Medical Group Ltd

BMGL US

Rennova Health, Inc.

RNVA US

Cardiff Lexington Corp

CDIX US